The Potential Use of Plant Natural Products and Plant Extracts with Antioxidant Properties for the Prevention/Treatment of Neurodegenerative Diseases: In Vitro, In Vivo and Clinical Trials
- PMID: 30544977
- PMCID: PMC6321248
- DOI: 10.3390/molecules23123283
The Potential Use of Plant Natural Products and Plant Extracts with Antioxidant Properties for the Prevention/Treatment of Neurodegenerative Diseases: In Vitro, In Vivo and Clinical Trials
Abstract
Neurodegenerative disorders, including Alzheimer's disease, Parkinson's disease and Huntington's disease, present a major health issue and financial burden for health care systems around the world. The impact of these diseases will further increase over the next decades due to increasing life expectancies. No cure is currently available for the treatment of these conditions; only drugs, which merely alleviate the symptoms. Oxidative stress has long been associated with neurodegeneration, whether as a cause or as part of the downstream results caused by other factors. Thus, the use of antioxidants to counter cellular oxidative stress within the nervous system has been suggested as a potential treatment option for neurological disorders. Over the last decade, significant research has focused on the potential use of natural antioxidants to target oxidative stress. However, clinical trial results have lacked success for the treatment of patients with neurological disorders. The knowledge that natural extracts show other positive molecular activities in addition to antioxidant activity, however, has led to further research of natural extracts for their potential use as prevention or treatment/management of neurodegenerative diseases. This review will cover several in vitro and in vivo research studies, as well as clinical trials, and highlight the potential of natural antioxidants.
Keywords: Ginkgo biloba; antioxidants; clinical trials; in vitro; in vivo; natural products; phenolics; phytochemicals; plant extracts; secondary metabolites.
Conflict of interest statement
The authors declare no conflict of interest.
Figures


















Similar articles
-
Ginkgo biloba and neurodegenerative disorders.Front Biosci. 2004 Sep 1;9:3091-104. doi: 10.2741/1462. Front Biosci. 2004. PMID: 15353340 Review.
-
Multiple antioxidants in the prevention and treatment of neurodegenerative disease: analysis of biologic rationale.Curr Opin Neurol. 1999 Dec;12(6):761-70. doi: 10.1097/00019052-199912000-00017. Curr Opin Neurol. 1999. PMID: 10676761 Review.
-
Lutein and the Underlying Neuroprotective Promise against Neurodegenerative Diseases.Mol Nutr Food Res. 2024 Jul;68(13):e2300409. doi: 10.1002/mnfr.202300409. Epub 2024 Mar 15. Mol Nutr Food Res. 2024. PMID: 38487969 Review.
-
Neuroprotective Potential and Underlying Pharmacological Mechanism of Carvacrol for Alzheimer's and Parkinson's Diseases.Curr Neuropharmacol. 2023;21(6):1421-1432. doi: 10.2174/1570159X21666221223120251. Curr Neuropharmacol. 2023. PMID: 36567278 Free PMC article. Review.
-
Emerging role of polyphenolic compounds in the treatment of neurodegenerative diseases: a review of their intracellular targets.Eur J Pharmacol. 2006 Sep 1;545(1):51-64. doi: 10.1016/j.ejphar.2006.06.025. Epub 2006 Jun 17. Eur J Pharmacol. 2006. PMID: 16904103 Review.
Cited by
-
Chemical Composition, Antioxidant Activity, Cytoprotective and In Silico Study of Ethanolic Extracts of Bougainvillea × buttiana (Var. Orange and Rose).Molecules. 2022 Oct 3;27(19):6555. doi: 10.3390/molecules27196555. Molecules. 2022. PMID: 36235092 Free PMC article.
-
Phytochemicals Targeting VEGF and VEGF-Related Multifactors as Anticancer Therapy.J Clin Med. 2019 Mar 12;8(3):350. doi: 10.3390/jcm8030350. J Clin Med. 2019. PMID: 30871059 Free PMC article. Review.
-
Ultrasonic-Assisted Extraction of Flavonoids from Juglans mandshurica Maxim.: Artificial Intelligence-Based Optimization, Kinetics Estimation, and Antioxidant Potential.Molecules. 2022 Jul 28;27(15):4837. doi: 10.3390/molecules27154837. Molecules. 2022. PMID: 35956798 Free PMC article.
-
Sterubin: Enantioresolution and Configurational Stability, Enantiomeric Purity in Nature, and Neuroprotective Activity in Vitro and in Vivo.Chemistry. 2020 Jun 5;26(32):7299-7308. doi: 10.1002/chem.202001264. Epub 2020 May 15. Chemistry. 2020. PMID: 32358806 Free PMC article.
-
Neuroprotective Potential of Limonene and Limonene Containing Natural Products.Molecules. 2021 Jul 27;26(15):4535. doi: 10.3390/molecules26154535. Molecules. 2021. PMID: 34361686 Free PMC article. Review.
References
-
- Prince M., Guerchet M., Prina M. World Alzheimer Report 2013. Alzheimer’s Disease International; London, UK: 2013.
-
- Dorsey E.R., Constantinescu R., Thompson J.P., Biglan K.M., Holloway R.G., Kieburtz K., Marshall F.J., Ravina B.M., Schifitto G., Siderowf A., et al. Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. Neurology. 2007;68:384–386. doi: 10.1212/01.wnl.0000247740.47667.03. - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases